The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 18, 2025
Filed:
Sep. 26, 2019
Applicant:
Merck Patent Gmbh, Darmstadt, DE;
Inventors:
Marat Alimzhanov, Wellesley, MA (US);
Patricia Soulard, Lexington, MA (US);
Frank Zenke, Darmstadt, DE;
Heike Dahmen, Darmstadt, DE;
Astrid Zimmermann, Muehltal, DE;
Andreas Schroeder, Heidelberg, DE;
Keyvan Tadjalli Mehr, Heidelberg, DE;
Martin Falk, Roedermark, DE;
Assignee:
Merck Patent GMBH, Darmstadt, DE;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 31/497 (2006.01); A61K 31/555 (2006.01); A61P 35/00 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2827 (2013.01); A61K 31/497 (2013.01); A61K 31/555 (2013.01); A61P 35/00 (2018.01); G01N 33/6866 (2013.01); G01N 2333/56 (2013.01); G01N 2333/565 (2013.01); G01N 2333/57 (2013.01); G01N 2800/52 (2013.01);
Abstract
The present invention relates to combination therapies useful for the treatment of cancer. In particular, the invention relates to a therapeutic combination which comprises a PD-1 antagonist, an ATR inhibitor and a platinating agent.